Simplex Trading’s Trinity Biotech TRIB Stock Holding History

Simplex Trading’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,640	Closed	-$18K	–	11405
2021 Q4	$18K	Buy	2,640 +540	+26%	+$5.1K	﹤0.01%	8495
2021 Q3	$30K	Hold	2,100	–	–	﹤0.01%	8098
2021 Q2	$30K	Buy	2,100 +2,091	+23,233%	+$34.8K	﹤0.01%	8241
2021 Q1	$16K	Buy	9 +7	+350%	+$168	﹤0.01%	7633
2020 Q4	$3K	Sell	2 -2	-50%	-$33	﹤0.01%	7909
2020 Q3	$3K	Buy	+4	New	+$46	﹤0.01%	7327
2017 Q1	–	Sell	-3	Closed	-$3K	–	6790
2016 Q4	$3K	Sell	3 -4	-57%	-$138	﹤0.01%	4817
2016 Q3	$1K	Sell	7 -2	-22%	-$125	﹤0.01%	5446
2016 Q2	$4K	Buy	+9	New	+$507	﹤0.01%	4480
2015 Q1	–	Sell	-1	Closed	-$1K	–	5598
2014 Q4	$1K	Buy	+1	New	+$86	﹤0.01%	4291

Other funds holding TRIB

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return

YAG

Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return

Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

MAWA

Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

BCM

Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Simplex Trading's TRIB Position: Q1 2026 in Review

Simplex Trading opened a new position in Trinity Biotech (TRIB) in Q1 2026: 555 shares worth $300. The stake represents ﹤0.01% of the portfolio and ranks #8797 among its holdings. This is a return to the name: Simplex Trading previously reported a position in TRIB as recently as Q3 2025.

Simplex Trading first reported a position in TRIB in Q4 2014 and has held it in 20 quarters since. The position peaked at $28K in Q1 2021. 23 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.

Simplex Trading held 555 shares of Trinity Biotech worth $300 as of Q1 2026.
Trinity Biotech was a new Simplex Trading position in Q1 2026.
Trinity Biotech made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8797 holding.
Simplex Trading first reported a position in Trinity Biotech in Q4 2014 and has held it in 20 quarters since.
Simplex Trading's Trinity Biotech position peaked at $28K in Q1 2021.
23 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.